Le Lézard
Classified in: Health, Business
Subject: ERN

Interim Report 1 January - 30 September 2019


STOCKHOLM, Nov. 14, 2019 /PRNewswire/ -- "Following a record first half year, sales weakened in the third quarter. However, the market situation and demand for our products remain favorable and we have confidence in our strategy"

 Johan Löf, CEO of RaySearch. Comments on page 2.

THIRD QUARTER (JULY-SEPTEMBER 2019)

NINE MONTHS (JANUARY-SEPTEMBER 2019)

SIGNIFICANT EVENTS DURING THE THIRD QUARTER

SIGNIFICANT events AFTER THE END OF THE REPORTING PERIOD

The information contained in this interim report was submitted for publication on November 14, 2019 at at 7:45 a.m. CET.

teleconference in connection with the interim report

CEO Johan Löf and CFO Peter Thysell will present RaySearch's interim report for January-September 2019 at a teleconference in English on Thursday, November 14, 2019 at 4:00 p.m. CET.

For login details to the teleconference, please register on:

http://emea.directeventreg.com/registration/3036698

FOR FURTHER INFORMATION, PLEASE CONTACT:

Johan Löf, President and CEO 

 Tel: +46 8 510 530 00 

 E-mail: [email protected]

Peter Thysell, CFO 

 Tel: +46 70 661 05 59 

 E-mail: [email protected]

ABOUT RAYSEARCH

RaySearch Laboratories AB (publ) is a medical technology company that develops innovative software solutions for improved cancer treatment. The company develops and markets the RayStation treatment planning system and RayCare oncology information system to cancer centers all over the world and distributes the products through licensing agreements with leading medical technology companies. RaySearch's software is currently used by over 2,600 centers in more than 65 countries. The company was founded in 2000 as a spin-off from the Karolinska Institute in Stockholm and the share has been listed on Nasdaq Stockholm since 2003. More information about RaySearch is available at www.raysearchlabs.com.

This information was brought to you by Cision http://news.cision.com

https://news.cision.com/raysearch-laboratories/r/interim-report-1-january---30-september-2019,c2961136

The following files are available for download:

https://mb.cision.com/Main/1102/2961136/1141012.pdf

The full report (PDF)

SOURCE RaySearch Laboratories


These press releases may also interest you

at 03:44
Bitrue, a leading cryptocurrency exchange serving over 10 million users globally, announces a focus on user behavior analysis to further develop the utility of its native token, Bitrue Coin (BTR). "Understanding how our users interact with BTR is...

at 03:04
Policybazaar, India's leading online insurance marketplace, is witnessing a significant increase in non-resident Indians (NRIs) choosing term insurance from India via its platform. This surge is driven by the unparalleled ease, affordability and...

at 02:00
C.K. McWhorter, chairman of the McWhorter Foundation, voices concerns over outdated perspectives in corporate leadership, exemplified by recent remarks from Nelson Peltz regarding Disney's film direction. After encountering instances of racism and...

at 02:00
OKX, a leading crypto exchange by trading volume and a leading Web3 technology company, has issued updates for March 29, 2024. OKX...

at 00:25
Shanghai Junshi Biosciences Co., Ltd ("Junshi Biosciences," HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced its financial...

at 00:24
In the news release, Roborock Reports 2023 Full Year Financial Results, issued 28-Mar-2024 by Roborock over PR Newswire, we are advised by the company that in the first bullet point of "Growth across Product Categories", the USD amount should read...



News published on and distributed by: